• Phase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Poland +1

  • Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Finland France Germany +10

  • Effect of denosumab versus zoledronic acid on erosion progression in patients with erosive hand osteoarthritis and osteoporosis: a randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Effect of Metformin Hydrochloride on Inflammation and Aging Biomarkers in Pre‑diabetic Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Advanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

    Not yet recruiting

    2 1
    Investigated Drugs:
    Bulgaria Czechia Hungary Italy Latvia Lithuania +4

  • Phase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Hungary Spain

  • A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

    Not yet recruiting

    2 1
    Investigated Diseases:
    Sweden

  • Feasibility of Sequential Radium Ra-223 Dichloride After Triplet Therapy in High‑Volume Metastatic Hormone‑Sensitive Prostate Cancer Patients (Phase II)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Phase II Study of [68Ga]Ga-FAP-2286 PET/CT for Staging and Restaging Newly Diagnosed Primary Breast Cancer Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Denmark

powered by